本页面由Tiger Trade Technology Pte. Ltd.提供服务

IGM Biosciences

1.27
0.0000
成交量:- -
成交额:206.61万
市值:7,657.17万
市盈率:-1.44
高:1.27
开:1.27
低:1.27
收:1.27
52周最高:22.50
52周最低:0.9200
股本:6,029.27万
流通股本:1,288.63万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.8789
每股收益(LYR):-3.2355
净资产收益率:-47.82%
总资产收益率:2.89%
市净率:0.76
市盈率(LYR):-0.39

数据加载中...

2024/03/28

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/07

重要事件披露

Form 8-K - Current report
2024/03/07

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/16

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/08

重要事件披露

Form 8-K - Current report
2023/11/16

SEC问询函

Form CORRESP - Correspondence
2023/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/13

重要事件披露

Form 8-K - Current report
2023/10/04

重要事件披露

Form 8-K - Current report
2023/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities